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IGIF Does Not Drive Th1 Development
but Synergizes with IL-12 for Interferon-g
Production and Activates IRAK and NFkB
1994; Paul and Seder, 1994; Romagnani, 1994; Abbas
et al., 1996). We and others have shown that IL-12 directs
Th1 development from antigen-stimulated naive CD41
T cell receptor (TCR) ab transgenic T cells (Hsieh et
al., 1993; Manetti et al., 1993; Seder et al., 1993). IL-12
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²Department of Molecular Biology activates signal transducer and activator of transcrip-
tion-3 (STAT3) and STAT4 in Th1 cells (Jacobson et al.,DNAX Research Institute
of Molecular and Cellular Biology 1995; Szabo et al., 1995), and STAT4 is required for Th1
responses in vivo (Kaplan et al., 1996; Thierfelder et al.,901 California Avenue
Palo Alto, California 94304 1996). Responsiveness to IL-12 is impaired in BALB/c
mice (Hsieh et al., 1995; Guler et al., 1996), which results
in the nonhealing Th2 response to L. major infection
(Scott et al., 1988; Heinzel et al., 1989).Summary
IFNg-inducing factor (IGIF) was discovered in studies
of IFNg production in a Proprionobacterium acnes±In thesestudies, IFNg-inducing factor (IGIF), unlike IL-12,
induced model of toxic shock (Okamura et al., 1995).did not drive Th1 development in BALB/c or C57BL/6
This cytokine was subsequently characterized as activemice, but like IL-1a, potentiated IL-12±driven Th1 de-
in promoting proliferation and IFNg production by Th1velopment in BALB/c mice. IGIF and IL-12 synergized
clones and lines and natural killer (NK) cells in both micefor IFNg production from Th1 cells. Unlike IL-1a, IGIF
and humans and was suggested to have potency similarhad no effect on Th2 cells. IGIF signaled through IRAK,
to that of IL-12 (Okamura et al., 1995; Micallef et al.,IL-1 receptor±associated kinase, to induce nuclear
1996; Ushio et al., 1996; Kohno et al., 1997). However,translocation of p65/p50 NFkB in Th1 cells. IL-1a had
the demonstration that Th1 responses were defectiveno effect on proliferation, cytokine production, or
in mice with a disrupted IL-12 gene confirmed a centralNFkB activation in Th1 cells but activated NFkB and
role of IL-12 in Th1 development (Magram et al., 1996).proliferation in Th2 cells. Thus, Th1 and Th2 cells may
The role of IGIF in Th1 development has not yet beendiffer in responsiveness and receptor expression for
assessed. Structural analysis and fold recognition sug-IL-1 family molecules. IGIF and IL-1a may differentially
gest that IGIF belongs to the IL-1 family (Bazan et al.,amplify Th1 and Th2 effector responses, respectively.
1996). This hypothesis is supported by the observation
that IGIF is synthesized as an inactive precursor thatIntroduction
requires cleavage by caspase 1 for activity (Ghayur et
al., 1997; Gu et al., 1997). We have recently demon-CD41 T helper (Th) cells can be divided into Th1 and
strated that IL-1a acts as a cofactor in IL-12±inducedTh2 subsets on the basis of their cytokine profile upon
Th1 development in BALB/c but not C57BL/6 mice, andantigen stimulation (Mosmann et al., 1986; Sher and
that IL-1a responsiveness is lost by committed Th1 cellsCoffman, 1992; Abbas et al., 1996). The Th1 subset pro-
and clones (K. S. et al., submitted), in agreement withduces interferon-g (IFNg) and mediates delayed-type
previous reports of loss of IL-1a binding by Th1 cloneshypersensitivity and protection against intracellular patho-
(Lichtman et al., 1988). IL-1a signaling takes place viagens, while the Th2 subset produces interleukin-4 (IL-4)
IL-1 receptor-associated kinase (IRAK), which activatesand IL-5 and is implicated in humoral and allergic re-
a cascade through NIK and CHUK kinases, leading tosponses (Mosmann et al., 1986; Romagnani, 1991; Sher
activation of nuclear factor kB (NFkB) (Cao et al., 1996;and Coffman, 1992; Abbas et al., 1996). Inappropriate
Malinin et al., 1997; Regnier et al., 1997).Th subset development can result in failure to clear patho-
In this study we show that IGIF, unlike IL-12, does notgens, as exemplified by the Th2 response of BALB/c
drive Th1 development but potentiates IL-12±inducedmice to the intracellular organismLeishmania major, and
Th1 development in BALB/c but not C57BL/6 mice. Fur-may contribute to immunopathology in human diseases
thermore, we show marked synergy between IGIF andsuch as atopic asthma and certain autoimmune disor-
IL-12 in inducing IFNg production from differentiatingders (Locksley and Scott, 1991; Romagnani, 1991; Sher
and committed Th1 cells from BALB/c and C57BL/6and Coffman, 1992). Understanding both the factors de-
mice, suggesting that both IL-12 and IGIF are requiredtermining development of Th1 or Th2 responses to anti-
for significant expression of the Th1 phenotype. Unlikegenic stimulation and the regulation of cytokine produc-
IL-12, IGIF does not activate STAT4 in Th1 cells, buttion from differentiated Th subsets may thus lead to
rather signals through the IRAK pathway to induce nu-beneficial manipulation of the immune response.
clear translocation of p65/p50 NFkB complex. In con-Cytokines present at the initiation of CD41 T cell re-
trast, IL-1a, which showed no effect on Th1 cells, acti-sponses determine whether a Th1 or Th2 T cell response
vated NFkB and induced proliferation of Th2 cells, whichpredominates (Swain et al., 1991; O'Garra and Murphy,
did not respond to IGIF. Th1 and Th2 cells thus differ in
responsiveness and receptor expression for IL-1 family³To whom correspondence should be addressed (e-mail: aog@
molecules, and IGIF and IL-1a may differentially amplifydnax.org).




IGIF Does Not Drive Th1 Development
but Potentiates IL-12±Induced
Th1 Development
In initial studies, IGIF was described as a factor that
could act independently of IL-12 in promoting IFNg pro-
duction from Th1 cells and suggested to be as potent
as IL-12 (Okamura et al., 1995; Micallef et al., 1996;
Kohno et al., 1997). Although IL-12 has been shown to
drive Th1 development (Hsieh et al., 1993; Macatonia et
al., 1993; Manetti et al., 1993; Seder et al., 1993), the
role of IGIF in Th1 development has not been assessed.
We therefore examined the effect of addition of IGIF,
alone or with IL-12, in inducing Th1 development from
naive D011.10 ovalbumin-specific TCR transgenic CD41
T cells (Murphy et al., 1990; Hsieh et al., 1993; Macatonia
et al., 1993) cultured for 7 days with irradiated dendritic
cells and ovalbumin peptide 323±339 (OVA323±339). T cells
were restimulated with dendritic cells or spleen antigen-
presenting cells (APC) and OVA, and IFNg was measured
in culture supernatants at 48 hr by enzyme-linked immu-
nosorbent assay (ELISA). As shown in Figure 1A, addi-
tion of IGIF to primary cultures of naive CD41 T cells
stimulated with dendritic cells did not itself induce Th1
development. However, IGIF potentiated IL-12±induced
Th1 development.
IGIF Potentiates IL-12±Induced Th1 Development
in BALB/c but Not C57BL/6 Mice
BALB/c mice preferentially develop IL-4 predominant
immune responses to L. major infection (Locksley and
Scott, 1991) and in vitro (Hsieh et al., 1995; Guler et al.,
1996). Our previous studies have shown that IL-1a is a
cofactor for IL-12±induced Th1 development in BALB/c
but not C57BL/6 mice (K. S. et al., submitted). Therefore,
the role of IGIF in Th1 development in C57BL/6 versus
BALB/c CD41 T cells was examined. Naive CD41 T cells
from BALB/c and C57BL/6 mice were stimulated with Figure 1. IGIF Does Not Drive Th1 Development, but Potentiates
IL-12±Driven Th1 Development in BALB/c but not C57BL/6 Miceplate-bound anti-CD3 and IL-2 (to exclude any role of
APC-derived factors) for 7 days in the presence or ab- (A) IGIF does not drive Th1 development but synergizes with IL-12
in Th1 development in BALB/c mice. Naive CD41 T cells fromsence of IGIF and/or IL-12. The cells were restimulated
DO11.10 TCR transgenic mice were cultured in 24 well plates at awith anti-CD3 and IL-2, and IFNg production was as-
density of 2.5 3 105 T cells in 2 ml with irradiated FACS-purifiedsessed at 48 hr. IGIF alone did not induce Th1 develop-
dendritic cells (1 3 104/well) and antigen for 7 days in the presence
ment in either mouse strain (Figure 1B). However, poten- of medium alone, IGIF, IL-12, or IGIF plus IL-12. Cells were then
tiation of IL-12±driven Th1 development by IGIF was restimulated at 2.5 3 105/ml with antigen presented either by den-
dritic cells (DC) or spleen APC (5 3 106/well) for 48 hr. IFNg wasobserved in this APC-free system in BALB/c but not
measured in 48 hr supernatantsby ELISA. Results are representativeC57BL/6 mice (Figure 1B). These results suggest that
of at least five independent experiments.IGIF acts directly on the T cell and that there is a strain
(B) IGIF potentiates IL-12±induced Th1 development from BALB/cdifference in T cell IL-12 responsiveness.
T cells, but not C57BL/6 T cells in an APC-free development culture.
Szabo et al. (1997) have recently defined themolecular Naive CD41 T cells from BALB/c or C57BL/6 mice (5 3 105/well)
basis of differential IL-12 responsiveness of murine Th were cultured for 7 days in 24-well plates coated with anti-CD3 with
either IL-2 alone (medium) or in combination with IGIF, IL-12, orsubsets by demonstrating the reciprocal regulation of
both IGIF and IL-12. Cells were restimulated with anti-CD3 and IL-2the IL-12Rb2 subunit by IL-4 and IFNg. IFNg up-regu-
for 48 hr.lates the IL-12Rb2 chain and counteracts the inhibitory
(C) IGIF potentiation of IL-12±induced Th1 development from naiveeffects of IL-4. Thus BALB/c mice, which produce a BALB/c T cells results in part from antagonism of the effects of
substantial amount of IL-4 (Hsieh et al., 1995; Guler endogenous IL-4. Naive BALB/c CD41 T cells were cultured for 7
et al., 1996), may down-regulate IL-12Rb2 expression, days with anti-CD3 and IL-2, in the presence of anti-IL-4 (11B11,
10 mg/ml), IL-12, IL-12 plus anti-IL-4, IGIF plus IL-12, or IGIF plusimposing the reported requirement for IFNg in Th1 devel-
IL-12 and anti-IL-4. Cells were then restimulated with anti-CD3 andopment. This raises the possibility that IGIF acts either
IL-2 for 48 hr. Results are representativeof three independent exper-to down-regulate IL-4 or to up-regulate IFNg directly,
iments.thus increasing the IL-12 responsiveness of BALB/c T
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Figure 2. IGIF Synergizes with IL-12 to In-
crease IFNg Production from Differentiating
Th1 Cells
(A) IGIF synergizes with IL-12 in secondary
cultures to increase IFNg production from dif-
ferentiating Th1 cells from both BALB/c and
C57BL/6 mice when dendritic cells (DC) are
used as APC for restimulation. Naive CD41 T
cells fromD011.10 (BALB/c) or TCR7 (C57BL/6)
TCR transgenic mice were cultured with anti-
gen and whole spleen cells for 7 days. Cells
(2.5 3 105 /well) were restimulated with anti-
gen presented by irradiated dendritic cells
(1 3 104/well) in medium alone or with IGIF,
IL-12, or IGIF plus IL-12 in the secondary cul-
ture for 48 hr; then supernatants were har-
vested and IFNg measured by ELISA. Results
are representativeof five independent experi-
ments.
(B) IGIF synergizes with IL-12 during restimu-
lation of differentiating Th1 cells to reveal Th1
development even in neutral conditions. Na-
ive T cells from C57BL/6 mice were cultured
in anti-CD3-coated 24-well plates (5 3 105/
well) with IL-2 (10 ng/ml) and medium alone,
IGIF, IL-12, or IGIF plus IL-12 for 7 days. Cells
were then restimulated with anti-CD3 and
IL-2 plus medium alone, IGIF, IL-12, or IGIF
plus IL-12 for 48 hr. IFNg was measured in
supernatants by ELISA. Results are typical of
three separate experiments.
Similar results were seen with BALB/c T cells
(data not shown).
cells. To test this hypothesis, anti-IL-4 antibodies were As shown in Figure 2A, IGIF induced a small increase
in IFNg production when added alone to Th1 cells re-added during culture of naive BALB/c CD41 T cells with
anti-CD3 and IL-2 in the presence or absence of IGIF stimulated with dendritic cells and antigen but showed
marked potentiation of IL-12±induced IFNg production.and IL-12. As shown in Figure 1C, anti-IL-4 antibodies
augmented IL-12±driven Th1 development from BALB/c In contrast to its effect on primary Th1 development,
IGIF potentiation of IL-12±induced IFNg production inT cells and partially counteracted the requirement of
IGIF. This result may not occur in mice from genetic secondary cultures was seen when either DO11.10
transgenic T cells (BALB/c) or TCR7 transgenic T cellsbackgrounds producing low levels of IL-4, such as
C57BL/6. Indeed, IGIF was not required to potentiate (C57BL/6) were used.
Marked potentiation of IFNg production by IL-12 andIL-12±driven Th1 development in C57BL/6 mice (Figure
1C), nor was there an effect with anti-IL-4 antibodies IGIF was also observed when Th1 cells were stimulated
with anti-CD3 in the absence of APC. Again, this synergy(data not shown).
occured in both BALB/c (data not shown) and C57BL/6
Th1 cells (Figure 2B). When both IGIF and IL-12 wereIGIF Synergizes with IL-12 in Inducing IFNg
included in secondary stimulation of T cells previouslyProduction from 1-Week±Stimulated
cultured with anti-CD3 and IL-2 for 1 week in the ab-Th1 Cells
Restimulation of 1 week±polarized Th1 cells with den- sence of IL-12, highly significant levels of IFNg were
also produced (Figure 2B). Indeed, the combination ofdritic cells and antigen, or anti-CD3, even in the pres-
ence of added IL-12, led to production of significantly IGIF with IL-12 in the secondary stimulation led to levels
of IFNg production from anti-CD3±stimulated cells simi-lower levels of IFNg than those observed upon restimu-
lation with splenic APC and antigen (Figure 2A, and K. lar to those from cells restimulated with antigen and
splenic APC. These data, obtained using an APC-freeS. et al., submitted). Th1 cells were derived from TCR
transgenic CD41 T cells from DO11.10 mice (BALB/c) or system in which endogenous IL-12 production could be
ruled out, suggest that IL-12 is not required for develop-from hen egg lysozyme peptide 74±88 (HEL74±88)±specific
TCR7 mice (C57BL/6) (S. B. H. et al., unpublished data) ment of the potential for Th1 cells to produce IFNg. Of
importance is that there is an absolute requirement forstimulated in the presence of IL-12 for 7 days. To test
the effect of IGIF on IFNg production from these devel- IL-12 in the induction of IFNg production from devel-
oping Th1 cells, which is dramatically enhanced by itsoping Th1 cells, IGIF and IL-12, either alone or in combi-
nation, were added to the 48 hr restimulation culture. synergy with IGIF.
Immunity
574
myristate acetate (PMA) and ionomycin, and were tested
for IFNg and IL-4 production and proliferation at 48 hr.
As shown in Figure 3A, IGIF alone had a minimal effect
on proliferation of polarized Th1 cells. Additive or syner-
gistic effects of IGIF and IL-12 on IFNg production and
proliferation were seen with both anti-CD3 and PMA
and ionomycin stimulation (Figure 3A). IGIF also acted
with IL-12 to potentiate proliferation and IFNg produc-
tion from Th1 clones in response to stimulation with
anti-CD3 and IL-2, or PMA/ionomycin, in agreement with
previous findings (Kohno et al., 1997) (Figure 3A). Of
note, maximal synergy between IL-12 and IGIF was seen
in conditions of suboptimal TCR stimulation, such as
by soluble anti-CD3 and IL-2, and even without TCR
engagement (Figure 3A). In contrast, IL-1a had nosignifi-
cant effect on proliferation or IFNg production by polar-
ized Th1 cells or Th1 clones (data not shown), either
alone or in combination with IL-12 (Figure 3A).
Previous reports show that IL-1a acts to support pro-
liferation and IL-4 responsiveness of Th2 clones (Green-
baum et al., 1988; Lichtman et al., 1988; Weaver et al.,
1988; McArthur and Raulet, 1993). In contrast to Th1
cells, IL-1a supported proliferation of polarized Th2 cells
and Th2 clones (data not shown), whereas IGIF, alone
or in combination with IL-12 or IL-4, had no effect on
proliferation or IL-4 production by polarized Th2 cells
(Figure 3B). IGIF, alone or in combination with IL-12, did
not induce IFNg production from committed Th2 cells
or clones (data not shown).
IGIF Does Not Induce STAT4 ActivationFigure 3. IGIF Potentiates IL-12±Induced Proliferation and IFNg
in Th1 CellsProduction from Committed Th1 Cells but Does Not Affect Th2 Cells,
Which Respond to IL-1a IL-12 activates both STAT3 and STAT4 in Th1 cells (Ja-
cobson et al., 1995; Szabo et al., 1995), and STAT4 isCommitted Th1 and Th2 cells were derived from naive CD41 T cells
from TCR7 TCR transgenic mice (C57BL/6 background) stimulated required for Th1 responses (Kaplan et al., 1996; Thier-
with antigen presented by irradiated splenic APC for three rounds felder et al., 1996). Our results suggest that IGIF cannot
of 1 week in the presence of IL-12 (10 ng/ml) and anti-IL-4 (10 mg/ replace IL-12 but acts to potentiate IL-12±induced IFNg
ml) (A) or IL-4 (10 ng/ml) and anti-IL-12 (10 mg/ml) (B), respectively.
production. We examined the ability of IGIF to induceCells were then rested in IL-2 prior to 48 hr culture (at 5 3 104/well)
STAT4 activation in committed Th1 cells and clones.with medium alone, IGIF, IL-12, IGIF plus IL-12, IL-1a, or IL-1a plus
Committed Th1 cells or Th1 clones, were rested in IL-2IL-12 in 96-well plates. These 48 hr cultures were in the presence
of either medium alone, soluble anti-CD3 (100 ng/ml) plus IL-2 (10 for 10 days. After a further 5 hr rest in medium with
ng/ml), or PMA (50 ng/ml) and ionomycin (500 ng/ml). IFNg or IL-4 reduced serum content (2% fetal calf serum [FCS]), cells
production was measured by ELISA, and proliferation was assessed were cultured for 30 min in medium alone, IL-12, IGIF,
by [3H]thymidine incorporation. Results are representative of three
or the combination of both cytokines. Nuclear lysatesseparate experiments, and similar results were seen with cells de-
were then prepared and run in electromobility gel shiftrived from DO11.10 TCR transgenic animals.
assays (EMSA) with a 32P-labeled m67SIE nucleotide
probe to detect STAT binding. To distinguish STAT4IGIF Synergizes with IL-12 to Stimulate Proliferation
from other STATs, supershifting was performed by pre-and IFNg Production by Committed
incubation of the lysate with an anti-STAT4 antibody,Th1 but Not Th2 Cells
NB34 (Guler et al., 1997). As shown in Figure 4, SIECommitted Th1 and Th2 populations were derived from
binding protein was detected in nuclear lysates fromDO11.10 and TCR7 TCR transgenic mice by repeated
Th1 cells stimulated with IL-12, and it was confirmed toantigenic stimulation of naive CD41 T cells with splenic
be STAT4 by supershifting with an antibody to STAT4.APC in the presence of IL-12 and anti-IL-4 antibodies
No induction of SIE binding activity was observed inor IL-4 and anti-IL-12 respectively. After three rounds
nuclear lysates from cells stimulated with IGIF. Theseof antigenic stimulation in the presence of polarizing
results show that IGIF, unlike IL-12, does not inducecytokines, these cells acquire a stable, committed Th
STAT4 activation in committed Th1 cells from eitherphenotype (Murphy et al., 1996). Polarized Th1 and Th2
BALB/c or C57BL/6 mice or from Th1 clones (Figure 4).cells and Th1 and Th2 clones (data not shown) were
Since the m67SIE probe detects STAT1 and STAT3 inthen rested for 10 days in IL-2 prior to 48 hr culture with
addition to STAT4 (Szabo et al., 1997), IGIF does notIGIF, IL-1a, and IL-12, alone or in combination. In these
appear to induce any of the STATs shown to act in Th1cultures cells were either unstimulated or were stimu-
lated with soluble anti-CD3 and IL-2 or with phorbol development and phenotype expression. Furthermore,
IGIF and IL-12 in Th1 Responses
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Figure 4. IGIF Does Not Activate STAT4
Nuclear lysates were prepared from committed Th1 cells from TCR7 Figure 5. IGIF, but Not IL-1a, Activates IRAK in Committed Th1 Cells
and DO11.10 TCR transgenic mice or from HDK 1 Th1 clones after
Committed Th1 cells from DO11.10 TCR transgenic mice (2 3 107
incubation in medium, IL-12, IGIF or IL-12 plus IGIF for 30 min.
cells) were rested in 2% FCS-containing medium for 5 hr and then
Lysates (2 mg of protein) were incubated for 15 min with either
in medium containing IGIF or IL-1a for 0, 5, 10, and 30 min. Whole-
anti-STAT4 antibody (NB34) or phosphate-buffered saline at room cell lysates were prepared and IRAK was immunoprecipitated with
temperature and then with 32P-labeled m67SIE double-stranded oli- a rabbit antiserum. Antibody complexes were separated by protein
gonucleotide probe. Complexes were run on 5.25% polyacrylamide A beads and then run on an SDS polyacrylamide gel and transfered
gels in 0.253 Tris-borate-EDTA. Bands were seen when samples to a membrane for Western blotting with the antiserum to IRAK.
were incubated with IL-12 but not IGIF, and supershift with anti- Bound antibody was detected with anti-rabbit±horseradish peroxi-
STAT4 antibody confirmed these bands as including STAT4 com- dase complex andvisualized with chemiluminescent substrate. After
plexes. Addition of IGIF did appear to influence bands seen with 5, 10, and 30 min in IGIF, an additional, higher molecular weight
IL-12. Similar results were seen in three separate experiments. band was seen, reflecting an increased molecular mass of IRAK,
presumably by autophosphorylation (IRAK-P). No such size increase
was seen with IL-1a. Similar results were seen in three experiments
and with the HDK1 Th1 clone.IGIF did not appear to increase IL-12±induced STAT4
activation.
IGIF Induces Activation of IL-1 Receptor±Associated or IL-12. Competition with unlabeled probe confirmed
Kinase (IRAK)and Nuclear Translocation the specificity of both the constitutive and IGIF-induced
of p65/p50 NFkB in Th1 Cells bands (Figure 6C). Supershifting with a panel of antibod-
IL-1a/b binds to IL-1 receptors and activates a signaling ies to various Rel family members showed that the
pathway that involves IL-1 receptor±associated kinase induced band was supershifted with both anti-p65 and
(IRAK) and ultimately leads to nuclear translocation of anti-p50 antibodies, whereas the constitutive band shifted
the transcription factor NFkB (Cao et al., 1996; Malinin only with anti-p50 (Figure 6). This indicates that a consti-
et al., 1997; Regnier et al., 1997). To test the possible tutive p50/p50 homodimer is expressed in the nucleus
participation of IRAK in IGIF-induced signaling, whole- of unstimulated Th1 cells and that IGIF induced nuclear
cell lysates were prepared from committed Th1 cells translocation of p65/p50 heterodimers. IGIF also in-
from DO11.10 mice stimulated with either IGIF or IL-1a duced nuclear translocation of p65/p50 NFkB com-
for 0, 5, 10, and 30 min. Lysates were incubated with plexes in committed Th1 cells from C57BL/6 mice (data
antiserum to IRAK (Cao et al., 1996); immunoprecipi- not shown). These data show that, unlike IL-12, IGIF
tated protein was then run on Laemmli gels and detected activates NFkB in Th1 cells, suggesting that these fac-
with the same antiserum. As shown in Figure 5, IGIF tors activate separate signal transduction pathways that
induced a time-dependent appearance of IRAK bands may interact to produce the synergistic biological ef-
with a higher molecular mass in Th1 cells, and this was fects observed.
not seen with IL-1a. Similar results were seen in Th1
clones (data not shown). This result suggests that IGIF
signals through a receptor that associates with IRAK Th2 Cells Do Not Respond to IGIF, but to IL-1a,
Which Induces Proliferation and Nuclearbut is distinct from the IL-1 receptor type 1, since IL-1a
does not act on these cells. This finding is in agreement Translocation of NFkB
To address whether differences in responsiveness be-with the observation that IGIF activity on NK cells is not
blocked by antibodies to either IL-1R1, IL-1R2, or the tween Th1 and Th2 cells resulted from differential activa-
tion of NFkB signaling in the two subsets by IGIF andIL-1 accessory receptor (Hunter et al., 1997), suggesting
that IGIF uses a novel IL-1R. Several orphan IL-1R mole- IL-1a respectively, nuclear lysates from committed Th1
and Th2 cells and Th1 and Th2 clones were analyzed.cules exist (Hardiman et al., 1996).
We next examined nuclear lysates from Th1 cells, As shown in Figures 7A and 7B, IGIF, but not IL-1a,
caused nuclear translocation of p65/p50 NFkB com-stimulated with IGIF, IL-12, IL-1a, or PMA and ionomycin
for 30 min, for binding activity to a 32P-labeled kB nucleo- plexes in Th1 cells but not Th2 cells. In contrast, IL-1a
activated p65/p50 NFkB complexes in Th2 cells but nottide probe. Inducible NFkB binding was seen both in
committed Th1 cells (Figure 6A) and in Th1 clones (Fig- Th1 cells. Taken together, these datasuggest that differ-
ential responsiveness of Th1 and Th2 cells to the IL-1ure 6B) incubated with IGIF (the higher molecular weight
band), whereas only a single constitutive band was seen family members IGIF and IL-1a may be determined at
the level of receptor expression. Moreover, the datain unstimulated cells and in cells stimulated with IL-1a
Immunity
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Figure 6. IGIF Induces Nuclear Translocation of p65/p50 NFkB Complexes in Th1 Cells
Nuclear lysates were prepared from DO11.10 Th1 polarized cells (A) and the Th1 clone HDK 1 (B and C) and cultured for 30 min with medium
alone, IL-1a, IL-12 or IGIF. Lysates were incubated with antibodies to Rel family members for 15 min and then with 32P-labeled double-stranded
oligonucleotide NFkB probe before they were run on 5.25% polyacrylamide gels in 0.253 Tris-borate-EDTA. A constitutive NFkB complex
was seen in Th1 cells, shown to be a p50/p50 homodimer by supershifting, and an additional NFkB complex, a p65/p50 heterodimer, was
seen after incubation with IGIF. (C) NFkB complexes were not seen after preincubation of lysates with nonlabeled probe (cold competition),
confirming the specificity of the bands observed. Similar results were seen in committed Th1 cells from TCR7 (C57BL/6) TCR transgenic mice
and in four separate experiments.
suggest that this difference may lead to differential am- responsiveness (Szabo et al., 1997), it is possible that
IGIF acts to reverse the inhibitory effect of IL-4 on IL-12plification of Th1 or Th2 responses by these factors
produced during innate immune responses. responsiveness of developing BALB/c Th1 cells. This
idea was supported by our finding that anti-IL-4 partially
Discussion
IL-12 knockout mice and STAT4 knockout mice have
indicated their critical role in Th1 responses (Kaplan et
al., 1996; Magram et al., 1996; Thierfelder et al., 1996).
Several cofactors for IL-12±driven Th1 responses have
been identified for particular genetic backgrounds, in-
cluding IL-1a in BALB/c mice (K. S. et al., submitted).
The reported structural similarity between IL-1a and IGIF
led us to investigate and compare the roles of IGIF and
IL-1a in Th1 development and in IFNg production from
committed Th1 cells and clones, including an analysis
of the signal transduction pathways. Our studies show
that IGIF does not in itself induce Th1 development, but
acts with IL-12 as an important amplifying factor for
IFNg production. The signal transduction pathway that
is activated by IGIF is the IL-1a pathway and includes
activation of IRAK and nuclear translocation of p65/p50
NFkB, but does not involve the IL-1R1 receptor. In con-
trast, IGIF has no activity in signaling effector functions
of Th2 cells, nor does it activate the NFkB pathway.
However, Th2 cells respond to another IL-1 protein, IL-
1a. The differential responsiveness between Th1 and
Th2 cells to IGIF and IL-1a respectively may have pro-
found implications for regulation of ongoing Th cell re-
sponses.
Figure 7. IGIF but Not IL-1a Activates p65/p50 NFkB in Th1 Cells,The finding that IGIF does not drive Th1 development
whereas IL-1a but Not IGIF Activates p65/p50 NFkB in Th2 Cellsis consistent with the requirement for IL-12 and STAT4
Committed Th1 and Th2 cells (A) and Th1 and Th2 clones (B) werefor Th1 responses (Kaplan et al., 1996; Magram et al.,
incubated with medium, IGIF, or IL-1a for 30 min, andnuclear lysates1996; Mattner et al., 1996; Thierfelder et al., 1996). IGIF,
were then made. Nuclear lysates (2 mg of protein) were incubated
like IL-1a, acted as a cofactor in IL-12±induced Th1 with antibodies to p65 (RelA) or p50 NFkB components or saline
development in BALB/c mice. We have previously and then with 32P-labeled double-stranded oligonucleotide NFkB
probe, and then were run on a 5.25% polyacrylamide gel. Constitu-shown that IL-1a and TNFa increase IL-12 respon-
tive p50/p50 complexes were observed in both Th1 and Th2 cells.siveness of developing BALB/c Th1 cells (K. S. et al.,
IGIF but not IL-1a induced p65/p50 complexes in Th1 cells. In con-submitted). Cofactors were not required for Th1 devel-
trast, IL-1a but not IGIF did so in Th2 cells. Both p65/p50 and p50/opment from CD41 T cells from C57BL/6 mice. BALB/c
p50 NFkB complexes were seen in Th1 cells stimulated with PMA
mice preferentially mount Th2 responses and IL-4 pro- and ionomycin (A). Results are representative of three separate ex-
duction (Hsieh et al., 1995). Since IL-4 has been shown periments.
to down-regulate the IL-12Rb2 subunit and hence IL-12
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obviated the effect of IGIF on IL-12±induced Th1 devel- Our findings on signaling by IGIF are in accordance
with the observed biology. IGIF, unlike IL-12, did notopment in BALB/c mice. It is possible that differences
in levels of IL-4 production during Th development de- induce STAT4 activation in Th1 cells and did not drive
Th1 development. Since IL-12 and STAT4gene deletionstermine in part the requirement for cofactors in IL-12±
induced Th1 development. We found that anti-IL-4 anti- lead to mice with defective Th1 responses, STAT4 acti-
vation appears to be a critical step in the activation ofbodies did not influence Th1 development from CD41
T cells from C57BL/6 mice. Our results may be relevant Th1 development (Jacobson et al., 1995; Szabo et al.,
1995; Kaplan et al., 1996; Thierfelder et al., 1996). Poten-for improving our understanding of responses to intra-
cellular pathogens. For example, susceptibility or resis- tial STAT4 response elements have been proposed
though not demonstrated in the IFNg promoter (Young,tance to L. major in various strains of mice is complex
and probably is controlled by several genetic loci (Beebe 1996), and the target genes of STAT4 in Th1 develop-
ment are not known. We show that, like IL-1a, IGIF sig-et al., 1997; Roberts et al., 1997). Although this may
result from regulation of the levelof IL-12Rb2 expression nals through IRAK, leading to nuclear translocation of
NFkB p65/p50 complexes. A number of NFkB sites haveby IL-4 or IFNg, it is possible that the immune response
is also affected by other cofactors, such as IGIF or IL- been described in the IFNg promoter and introns (Young,
1996), so it is likely that IGIF-induced p65/p50 acts di-1a, and by their interplay with T cells and NK cells (Ban-
croft et al., 1989; D'Andrea et al., 1992; Scharton and rectly on the IFNg promoter, presumably in cooperation
with other transcription factors induced via STAT4 acti-Scott, 1993).
In an APC-free system, IGIF showed marked synergy vation. However, IGIF signaling and responses were
confined to Th1 cells, whereas in agreementwith a previ-with IL-12 in inducing IFNg production by developing
Th1 cells from both BALB/c and C57BL/6 mice. Further- ous report (Lederer et al., 1996) only Th2 cells showed
NFkB activation and proliferation to IL-1a. Thus, al-more, the addition of IGIF plus IL-12 in the secondary
stimulation of T cells in this system revealed that Th1 though IL-1a and IGIF share signaling machinery, these
molecules have widely divergent effects on differenti-development can occur in the absence of IL-12. This
IL-12±independent Th1 development was abrogated by ated Th cell subsets. It has been shown that IL-1a/b
receptors are lost on Th1 clones (Lichtman et al., 1988),antibodies to IFNg (data not shown), a finding in keeping
with previous reports that IFNg can direct Th1 develop- and IGIF activity on NK cells is not blocked by antibodies
to IL-1R1, IL-1R2, or IL-1R3 (Hunter et al., 1997). Differ-ment through effects on both T cells and APC (Sher and
Coffman, 1992; Seder et al., 1993; Dighe et al., 1995; ences in the activity of IGIF and IL-1a may therefore
be determined at the level of receptor expression. IL-1Lohoff et al., 1997; Taki et al., 1997). However, we show
that IL-12 is absolutely required for induction of IFNg receptors and the related Toll receptors activate NFkB
(Medzhitov et al., 1997; Regnier et al., 1997), and thisproduction from developing Th1 cells and that this ac-
tion is markedly augmented by IGIF. This requirement pathway is widely conservedacross Drosophila melano-
gaster, mammalian cells, and plants (Wilson et al., 1997).was not previously appreciated because Th1 cells were
typically restimulated in cultureswith antigen and spleen It has an important role in development and is critical
in the innate immune response. The actions of IGIF viaAPC, which may have provided endogenous levels of
IGIF, and low levels of IL-12 (Murphy et al., 1994). This IRAK and NFkB in Th1 cells and the actions of IL-1a via
IRAK and NFkB in Th2 cells may represent an importanteffect of IL-12 and IGIF may overcome the inhibition by
endogenous factors acting to suppress IFNg production interface between the innate and acquired immune re-
sponses. Thus these IL-1 family members may act onin differentiating Th1 populations, which are heteroge-
neous in terms of cytokine production (Openshaw et al., specific limbs of T cell activation, with IGIF acting in
concert with IL-12 to amplify Th1 responses and IL-1a/b1995; Murphy et al., 1996).
IGIF had minimal effect alone on inducing IFNg pro- enhancing Th2 responses.
In summary, IGIF does not by itself drive Th1 develop-duction from committed Th1 cells or Th1 clones, in con-
trast to previously reported findings in Th1 cell lines ment and does not activate STAT4, in contrast to IL-12.
However like IL-1a, IGIF potentiates IL-12±driven Th1and clones (Kohno et al., 1997). The cells used in our
experiments had previously been rested in IL-2±contain- development in BALB/c but not C57BL/6 mice. The ma-
jor effect of IGIF in both BALB/c and C57BL/6 mice ising media and were used at least 10 days after their last
antigenic stimulation to avoid any carry-over effect of synergy with IL-12 for expression of the Th1 phenotype
through IFNg production. These findings indicate thatantigenic stimulation, which may explain this apparent
discrepancy. In agreement with the findings of Kohno signals from both IL-12 and IGIF are required to induce
significant levels of IFNg production from resting Th1et al. (1997), we observed synergy between IGIF and IL-
12 in induction of IFNg production from committed Th1 effector cells. This is supported by the effects on Th1
responses in vivo, observed either by removal of IL-12cells and clones. Indeed, this synergy was observed
even in the absence of TCR stimulation or in conditions (Magram et al., 1996) or neutralization of IGIF (Okamura
et al., 1995). Taken together, these data argue for theof suboptimal TCR stimulation. This raises the possibility
of considerable amplification of Th1 responses by the relevance of this synergy between IL-12 and IGIF and
thus the signals through STAT4 and NFkB in host protec-combination of IGIF and IL-12 in vivo, and it is possible
that bystander activation of previously committed Th1 tion against intracellular pathogens and in possible in-
duction of immunopathology. This raises the possibilitycells of different antigen specificities might contribute
to this amplification. Moreover, such bystander Th1 acti- that intervention in the actions of either or both IL-12
and IGIF might hold therapeutic potential, either in aug-vation has the potential for harmful activation of memory
Th1 cells cross-reactive with self-antigens. menting protective Th1 responses, as in mycobacterial
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Stimulation of Transgenic CD41T Cells for Cytokine Productiondisease, or in diminishing damaging Th1 responses, as
Primary stimulations of CD41T cells (2.5 3 105/well) were carriedin autoimmune disease.
out using OVA (0.6 mM) or HEL (1 mM) and irradiated dendritic cells
(1 3 104/well, 1000 rad) or red blood cell±lysed spleen cells (5 3
Experimental Procedures 106/well, 3000 rads) as APC in a total volume of 2 ml in 24-well
plates. In some cases, antigen and APC were replaced by cross-
Animals linked anti-CD3 (10 mg/ml) plus IL-2 (10 ng/ml), when 5 3 105 cells
Mice transgenic for an ab TCR recognizing OVA323±339 (D011.10; were used per 2 ml well in 24-well plates. Some cultures also re-
BALB/c genetic background) (Murphy et al., 1990) were selected at ceived IGIF at 30 ng/ml or IL-12 (10 ng/ml), either separately or in
age 4±6 weeks by staining peripheral blood leukocytes with the anti- combination. This concentration of IGIF gave optimal proliferation
clonotype monoclonal antibody (MAb) KJ1±26 (Haskins et al., 1983). and cyokine production from a Th1 clone (data not shown). In addi-
Mice transgenic for an ab TCR recognizing a peptide of hen egg tion, some cultures received 11B11 MAb to block endogenous IL-4
lysozyme, HEL74±88 (TCR7, C57BL/6 background; S. B. H. et al., un- (10 mg/ml). T cells were expanded 3-fold into fresh medium at 72
published data) were selected at age 4±6 weeks by polymerase hr. Cells were harvested on day 7, washed three times, counted,
chain reaction analysis for the rearranged transgenic TCR. All and restimulated with fresh APC (splenocytes or dendritic cells)
transgenic mice used in the experiments were heterozygous for the and 0.6 mM OVA or 1 mM HEL. Cultures previously stimulated with
integration of the TCR ab chains. BALB/c mice 6±10 weeks old were anti-CD3 plus IL-2 were restimulated with anti-CD3 plus IL-2. Cell
purchased from Simonsen (Gilroy, CA); C57BL/6 mice between 6±10 concentrations were as described for primary stimulation. Some
weeks old were purchased from Jackson (Bar Harbor, ME). cultures also received IGIF (30 ng/ml) or IL-12 (10 ng/ml), either
separately or in combination during the restimulation. Supernatants
were collected at 48 hr for measurement of IL-4 and IFNg.Culture Medium, Cytokines, Antibodies, and Antigens
RPMI 1640 (JR Scientific, Woodland, CA) supplemented with 10%
FCS (JR Scientific), 2-mercaptoethanol (0.05 mM, Sigma, St. Louis,
Committed Th1/Th2 Cells and Th1 ClonesMO), L-glutamine (2 mM), penicillin (100 U/ml), streptomycin (100
Committed Th1 and Th2 cells were derived from naive TCRmg/ml), HEPES buffer (10 mM), and sodium pyruvate (1 mM) was
transgenic CD41 T cells as previously described (Murphy et al.,used as culture medium (cRPMI). For dendritic cells isolations, RPMI
1996). In brief, cells were cultured with antigen (OVA323±339 or HEL74±88)1640 Dutch modification (Gibco, Life Technologies, Irvine, Scotland)
and splenic APC in the presence of IL-12 (10 ng/ml) and anti-IL-4was used with glutamine, FCS, penicillin, and streptomycin as de-
(10 mg/ml) to induce Th1 development or in the presence of IL-4 (10scribed above.
ng/ml) and anti-IL-12 (10 mg/ml) to produce a Th2 population. CellsRecombinant mouse cytokines were IGIF (produced by expres-
were harvested at 7 days and restimulated with fresh APC andsion in Escherichia coli); IL-2 and IL-4 (DNAX); TNFa (Genzyme,
antigen in the presence of polarizing cytokines, and this processCambridge, MA); and IL-1a (a kind gift from P. Lomedico, Roche,
was repeated for a third cycle. By three rounds of stimulation, TNutley, NJ). Recombinant mouse IL-12 was obtained from Phar-
cells achieve a stable, committed Th1 or Th2 phenotype (Murphymingen (San Diego, CA) (Schoenhaut et al., 1992).
et al., 1996).Purified rat anti-mouse IL-4, 11B11 (Ohara and Paul, 1985), and
The Th1 clone HDK1 is a keyhole limpet hemocyanin±specificisotype-matched control immunoglobulins (Abrams, 1995) were
clone from a BALB/c mouse (Cherwinski et al., 1987).supplied by J. Abrams (DNAX). The hybridomas secreting anti-IL-
Both committed Thpopulations and Th1 clonewere used in exper-12 MAbs (C17.8.20) were a kind gift from Giorgio Trinchieri (Ozmen
iments at least 10 days after their last antigen stimulation and afteret al., 1994). MAbs used for flow cytometry included anti-mouse
culture in medium with IL-2 alone. Cells were stimulated in 96-wellMac-1 (M1/70, Caltag, San Francisco, CA) and hamster anti-mouse
plates at 5 3 104/well for 48 hr with medium, soluble anti-CD3 (100N418, ATCC (Metlay et al., 1990), and isotype controls. For enrich-
ng/ml) and IL-2 (10 ng/ml), or PMA (50 ng/ml) and ionomycin (500ment of CD41T cells by magnetic activated cell sorting, biotinylated
ng/ml). In some cultures IGIF (30 ng/ml), IL-12 (10 ng/ml), and/oranti-mouse CD8a, B220, GR-1, Mac-1, and either anti I-Ad (BALB/
IL-1a (10 ng/ml) were added either separately or in combination.c) or I-Ab (C57BL/6) (Pharmingen) were used. Enriched populations
Supernatants were collected at 48 hr and assayed for IFNg and IL-4.were then stained with anti-mouse CD4 fluorescein isothiocyanate
Proliferation was assessed by addition of 1 mCi of [3H]thymidine perand anti-Mel-14 phycoerythrin (Pharmingen).
well for 6 hr.For cultures, azide-free, low-endotoxin anti-CD3e was obtained
from Pharmingen. Additional MAbs for ELISA, including anti-IL-4
and anti-IFNg, were as previously described (Abrams, 1995; Abrams
Cytokine Assays
et al., 1992; Macatonia et al., 1993).
IFNg was detected using a two-site sandwich ELISA (Slade and
The antigenic peptide from chicken ovalbumin (OVA323±339) and hen Langhorne, 1989; Abrams, 1995), and sensitivity was 125 pg/ml (1
egg lysozyme (HEL74±88) were synthesized on an Applied Biosystems unit/ml 5 0.1 ng/ml). The ELISA for IL-4 has been described pre-
(Foster City, CA) model 430 peptide synthesizer. viously (Abrams, 1995) with a level of detectability at 150 pg/ml.
Preparation of T Cells and APC
CD41 T cells were enriched by negative selection using magnetic Preparation of Nuclear and Whole-Cell Lysates
Prior to the preparation of cell lysates, 1±2 3 107 Th1 or Th2 cellsactivated cell sorting with a cocktail of biotinylated anti-CD8a, anti-
I-Ad, anti-B220, anti-GR1, and anti-Mac-1 antibodies, followed by were incubated in cRPMI with 2% FCS for 5 hr and then cultured
at 1 3 106/ml for 30 min in prewarmed medium containing cytokinesstreptavidin-conjugated microbeads (Miltenyi, Sunnyvale, CA). En-
riched CD41T cells were then further purified using a FACStarPlus at 378C for nuclear lysates and 0, 5, 10, and 30 min for whole-cell
lysates. Cytokine concentrations were IGIF 30 ng/ml, IL-1a 10 ng/flow cytometer (Becton Dickinson) to achieve more than 99% naive
CD41 T cells on the basis of bright Mel-14, CD41 staining (Bradley ml, and IL-12 10 ng/ml. PMA and ionomycin were used at 50 and
500 ng/ml, respectively. Nuclear extracts were prepared as de-et al., 1991). Staining did not alter the function of the T cells (data
not shown). scribed (Mui et al., 1995). In brief, cells were pelleted and cell mem-
branes then disrupted by brief (1 min) incubation in PSB buffer (50Dendritic cells were enriched from either BALB/c or C57BL/6
spleen cell preparations as described previously (Macatonia et al., mM HEPES, 100 mM NaF, 10 mM NaPPi, 2 mM NaVO4, and 4 mM
EDTA [all from Sigma]) with 0.2% Nonidet P-40 (NP-40) (Boehringer1989, 1993) by first removing adherent cells by overnight culture
in plastic flasks, followed by overlayering onto 2 ml metrizamide Mannheim, Indianapolis, IN) and 10 mM MgCl2. Cells were then
washed in 0.05% NP-40 with sucrose and 10 mM MgCl2 and nucleigradients (analytical grade, 13.7%, Nycomed Pharma AS, Oslo, Nor-
way) and centrifugation for 10 min at 600 3 g to yield a population lysed in 0.1% NP-40 in PSB. Protease inhbitors (leupeptin, aprotinin
[Sigma], and Pefabloc [Boehringer Mannheim]) were added to allenriched for dendritic cells in the low-density fraction. Dendritic
cells (N418hiMac-1lo) were further purified to homogeneity by flow solution used. Whole-cell lysates were prepared in PSB with 0.5%
NP-40.cytometry as previously described (Macatonia et al., 1993).
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Immunoprecipitation and Western Blot Analysis Characterization of antigen-specific CD41 effector T cells in vivo:
immunization results in a transient population of Mel-142, CD45RB2Rabbit antiserum to IRAK was a kind gift from Zhaodan Cao, Tularik
(South San Francisco, CA). (Cao et al., 1996). One microliter was helper cells that secretes interleukin 2(IL-2), IL-3, IL-4 and interferon
g. J. Exp. Med. 174, 547±559.added to 1 ml of whole-cell lysate and incubated for 2 hr, after which
protein A beads (Santa Cruz Biotechnology, Santa Cruz, CA) were Cao, Z., Henzel, W.J., and Gao, X. (1996). IRAK: a kinase associated
added for an additional 2 hr. Beads were then boiled in sodium with the interleukin-1 receptor. Science 271, 1128±1131.
dodecyl sulfate (SDS) buffer for 3 min and proteins separated by Cherwinski, H.M., Schumacher, J.H., Brown, K.D., and Mosmann,
SDS polyacrylamide gel electrophoresis (Novex, San Diego, CA). T.R. (1987). Two types of mouse helper T cell clone. III. Further
Separated proteins were transfered to a PVDF membrane (Millipore, differences in lymphokine synthesis between Th1 and Th2 clones
Bedford MA), and then Western blotting was performed with antise- revealed by RNA hybridization, functionally monospecific bio-
rum to IRAK at 1:1000 dilution overnight. Western blots were devel- assays, and monoclonal antibodies. J. Exp. Med. 166, 1229±1244.
oped with anti-rabbit antibody±horseradish peroxidase (Amersham,
D'Andrea, A., Rengaraju M., Valiante, N.M., Chemini, J., Kubin, M.,Arlington Heights, IL) and chemiluminesence substrate (Pierce,
Aste, M., Chan, S.H., Kobayashi, M., Young, D., Nickbarg, E., et al.Rockford, IL).
(1992). Production of natural killer cell stimulatory factor (interleukin
12) by peripheral blood mononuclear cells. J. Exp. Med. 176, 1387±Oligonucleotide Probes and Antibodies for Supershift Assay
1398.Double-stranded oligonucleotide probes used in EMSA were m67SIE,
Dighe, A.S., Campbell, D., Hsieh, C.-S., Clarke, S., Greaves, D.R.,CATTTCCCGTAAATC (sense sequence, no overhang); and NFkB
Gordon, S., Murphy, K.M., and Schreiber, R.D. (1995). Tissue-spe-consensus, gatcCAACGCAGGGGAATCTCCCTCTCCTTA(sense se-
cific targeting of cytokine unresponsiveness in transgenic mice.quence, with overhang shown in lower case). Probes were end-
Immunity 3, 657±666.labeled with [32P]ATP. The anti-STAT4 MAb NB34 was a kind gift
Ghayur, T., Banerjee, S., Hugunin, M., Butler, D., Herzog, L., Carter,from Nils Jacobson, Washington University (St. Louis, MO) (Guler
A., Quintal, L., Sekut, L., Talanian, R., Paskind, M., et al. (1997).et al., 1997). Antibodies to Rel family members cRel, RelB, p50, p52,
Caspase-1 processes IFN-g inducing factor and regulates LPS-and p65 (RelA) were from Santa Cruz Biotechnology.
induced IFN-g production. Nature 386, 619±623.
EMSA Greenbaum, L.A., Horowitz, J.B., Woods, A., Pasqualini, T., Reich,
EMSA was performed as previously described (Mui et al., 1995). E. and Bottomly, K. (1988). Autocrine growth of CD41 T cells: differ-
Nuclear extracts (2 mg of protein) were incubated with 1 pmol 32P- ential effects of IL-1 on helper and inflammatory T cells. J. Immunol.
labeled oligonucleotide probe in binding buffer and 1 mg of poly- 140, 1555.
dIdC (Pharmingen) for 15 min at room temperature and then run Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M.A., Hay-
on 5.25% polyacrylamide gels in 0.253 Tris-borate-EDTA. In some ashi, N., Higashino, K., Okamura, H., Nakanishi, K., et al. (1997).
cases an excess of unlabeled oligonucleotide probe (1003) was Activation of Interferon-g inducing factor mediated by interleukin
added to lysates for 10 min before the addition of labeled probe. 1-b converting enzyme. Science 275, 206±209.
Antibody supershifts were performed by preincubating with 1 mg of
Guler, M.L., Gorham, J.D., Hsieh, C.-S., Mackey, A.J., Steen, R.G.,NB34 in 2 ml to identify STAT4, or 2 ml of anti-Rel family antibodies
Dietrich, W.F., and Murphy, K.M. (1996). Genetic susceptibility toto identify NFkB components, for 15 min before the addition of
Leishmania: IL-12 responsiveness in TH1 cell development. Scienceoligonucleotide probes.
271, 984±987.
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